目的：自体外周血干细胞移植（APBSCT）是治疗儿童恶性实体瘤的重要方法之一，干细胞动员与采集是决定造血重建的重要因素。本研究采用CIE及IEV动员方案对儿童神经母细胞瘤（NB）及横纹肌肉瘤进行干细胞动员和采集，并对临床效果进行评价。方法：8例IV期NB 患儿采用CIE化疗方案动员，3例III期横纹肌肉瘤患儿采用IEV方案。观察采集干细胞的效果。结果：11例患儿平均采集单个核细胞数（MNC）为(5.55 ±1.43)×108/kg，CD34+ 细胞数为（4.88±2.48）×106/kg，动员并发症少,患儿均能耐受。10例行APBSCT后均获快速造血功能重建，其中1例NB于APBSCT后32 d因合并左心衰竭死亡，余9例患儿APBSCT后60 d复查外周血象稳定。结论：CIE及IEV方案可以安全有效地完成NB及横纹肌肉瘤自体外周血干细胞动员和采集并达到移植要求。
Abstract
OBJECTIVE: Autologous peripheral blood stem cell transplantation (APBSCT) is an important method for treatment of malignant solid tumors in children. The mobilization and collection of blood stem cells is crucial for APBSCT. This study aimed to evaluate the clinical efficacy of mobilization and collection of blood stem cells by CIE or IEV chemotherapy protocol in APBSCT in children with neuroblastoma (NB) or rhabdomyosarcoma. METHODS: The protocols of CIE (cisplatin, etoposide) and IEV (vincristine, dosfamide, etoposide) were used as mobilization chemotherapy in 8 cases of NB with stage IV and 3 cases of rhabdomysacoma with stage III, respectively. The results of the mobilization of blood stem cells were observed. RESULTS: Of the 11 cases, mononuclear cells (MNC) and CD34+ cells were successfully collected and the volume of MNC and CD34 averaged (5.55±1.43)×108/kg and (4.88±2.48)×106/kg, respectively. No severe complications were observed during the mobilization and collection. A rapid hemopoietic reconstitution was observed in 10 children after APBSCT. One with NB out of the 10 children died of left heart failure 32 days after APBSCT. Others (9 cases) showed a nearly normal result of routine peripheral blood test 60 days after APBSCT. CONCLUSIONS: CIE or IEV protocol is effective and safe for the mobilization and collection of peripheral blood stem cells in children with NB or rhabdomysacoma.
关键词
动员 /
自体外周血干细胞 /
神经母细胞瘤 /
横纹肌肉瘤 /
儿童
Key words
Mobilization /
Autologous peripheral blood stem cell /
Neuroblastoma /
Rhabdomyosarcoma /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
［1］冯晨，唐锁勤，王建文，刘英，杨光. CDV与CIE两种方案联合术前化疗治疗晚期儿童神经母细胞瘤的近期疗效观察［J］.中国当代儿科杂志，2009，11（11）：885-887.
［2］徐莹，唐锁勤，王建文，刘英，刘立真.13例小儿横纹肌疗效分析［J］.中国当代儿科杂志，2008，10（2）：163-166.
［3］Brodeur GM, Seeger RC, Barrett A, Berthold F, Castleberry RP, D′Angio G, et al. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma［J］. J Clin Oncol, 1988, 6(12): 1874-1881.
［4］张谊，黄东生，张伟令，王一卓，朱霞，洪亮，等. 大剂量化疗结合外周血干细胞移植治疗横纹肌肉瘤疗效分析［J］.中国小儿血液与肿瘤杂志，2010，15（3）: 115-117.
［5］黄东生,唐锁勤,王建文,刘立真,冉崇蓉,吕善根.CEM方案预处理结合自体外周血干细胞移植治疗晚期NB5例观察［J］.中国实用儿科杂志, 2004,19(9): 532-534.
［6］Bearman SI, Appelbaum FR, Buckner CD, Petersen FB, Fisher LD, Clift RA, et al. Regimen related toxicity in patients undergoing bone marrow transplantation［J］.J Clin Oncol,1988, 6(10):1562.
［7］Balduzzi A, Perseghin P, Dassi M, Bonanomi S, Rovelli A, Gaipa G, et al. Peripheral blood stem cell collection in children with acute leukemia: effectiveness of the ‘DIAVE’. mobilizing regimen［J］. Bone Marrow Transplant, 2002, 30(7): 413-416.
［8］Tang S, Huang D, Wang J, Wei X, Ran C, Peng Y, et al. Application of autologous peripheral blood stem cell transplantation in children with maligant tumor［J］. Clin Med J (Engl), 2001,114(10):1098-1101.
［9］Sevilla J, Plaza SF, González-Vicent M, Lassaletta A, Ramírez M, Madero L, et al. PBSC collection in extremely low weight infants: a single-center experience［J］. Cytotherapy, 2007, 9(4): 356-361.
［10］Cecyn KZ, Seber A, Ginani VC, Goncalves AV, Caram EM, Oguro T, et al. Large-volume leukapheresis for peripheral blood progenitor cell collection in low body weight pediatric patients: a single center experience［J］. Transfus Apher Sci, 2005, 32(3): 269-274.
［11］Sevilla J, Gonzalez-Vicent M, Madero L, García-Sánchez F, Angel Diaz M. Large volume leukapheresis in small children: safety profile and variables affecting peripheral blood progenitor cell collection［J］. Bone Marrow Transplant, 2003, 31(4): 263-267.
PDF(917 KB)
